Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

Wang, Qihui, Zhang, Yanfang, Wu, Lili, Niu, Sheng, Song, Chunli, Zhang, Zengyuan, Lu, Guangwen, Qiao, Chengpeng +6 more·2020·Cell

Cited by (1,009)

Items 601–700 of 1,009

  1. Versatile role of ACE2-based biosensors for detection of SARS-CoV-2 variants and neutralizing antibodies
    Jong-Hwan Lee, Yungmin Lee, Sung Kyun Lee, Jung Kim, Chang‐Seop Lee, Nam Hoon Kim, Hong Gi Kim · 2022 · Biosensors and Bioelectronics
  2. AGTR2, One Possible Novel Key Gene for the Entry of SARS-CoV-2 Into Human Cells
    Chunmei Cui, Chuanbo Huang, Wanlu Zhou, Xiangwen Ji, Fenghong Zhang, Liang Wang, Yuan Zhou, Qinghua Cui · 2020 · IEEE Transactions on Computational Biology and Bioinformatics
  3. Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discovery
    Paulchamy Chellapandi, Sivashanmuga Vadivel Saranya · 2020 · Medicinal Chemistry Research
  4. Comprehensive annotations of the mutational spectra of SARS‐CoV‐2 spike protein: a fast and accurate pipeline
    M. Shaminur Rahman, M. Rafiul Islam, M. Nazmul Hoque, A. S. M. Rubayet Ul Alam, Masuda Akther, Joynob Akter Puspo, Salma Akter, Azraf Anwar, Munawar Sultana, M. Anwar Hossain · 2020 · Transboundary and Emerging Diseases
  5. Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies
    Girish Pathangey, Priyal Fadadu, Alexa R. Hospodar, Amr E. Abbas · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  6. Intermolecular π–π Stacking Interactions Made Visible
    Brian J. J. Timmer, Tiddo J. Mooibroek · 2020 · Journal of Chemical Education
  7. Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
    Tingting Li, Xiaojian Han, Chenjian Gu, Hangtian Guo, Huajun Zhang, Yingming Wang, Chao Hu, Kai Wang, Fengjiang Liu, Feiyang Luo et al. · 2021 · Nature Communications
  8. The Genetic Variant of SARS-CoV-2: Would it matter for Controlling the Devastating Pandemic?
    Shuxin Guo, Kefang Liu, Jun Zheng · 2021 · International Journal of Biological Sciences
  9. SARS-CoV-2 Omicron Variant Binds to Human Cells More Strongly than the Wild Type: Evidence from Molecular Dynamics Simulation
    Hoang Linh Nguyen, Nguyen Quoc Thai, Phuong Hoang Nguyen, Mai Suan Li · 2022 · The Journal of Physical Chemistry B
  10. Molecular insights into the adaptive evolution of SARS-CoV-2 spike protein
    Zhuocheng Yao, Lin Zhang, Yuange Duan, Xiaolu Tang, Jian Lü · 2024 · Journal of Infection
  11. The impact of structural bioinformatics tools and resources on SARS-CoV-2 research and therapeutic strategies
    Vaishali Waman, Neeladri Sen, Mihály Váradi, Antoine Daina, Shoshana J. Wodak, Vincent Zoete, Sameer S Velankar, Christine Anne Orengo · 2020 · Briefings in Bioinformatics
  12. The Role of the SARS-CoV-2 S-Protein Glycosylation in the Interaction of SARS-CoV-2/ACE2 and Immunological Responses
    Eleazar Ramírez Hernández, Luis Fernando Hernández-Zimbrón, Nayeli Martínez-Zúñiga, Juan José Leal-García, Violeta Ignacio Hernández, Luis Eduardo Ucharima-Corona, Eduardo Pérez‐Campos, Edgar Zenteno · 2021 · Viral Immunology
  13. Production of high‐quality SARS‐CoV‐2 antigens: Impact of bioprocess and storage on glycosylation, biophysical attributes, and ELISA serologic tests performance
    Rute Castro, Lígia S. Nobre, Rute P. Eleutério, Mónica Thomaz, António Pires, Sandra Monteiro, Sónia Mendes, Ricardo A. Gomes, João J. Clemente, Marcos F. Q. Sousa et al. · 2021 · Biotechnology and Bioengineering
  14. Lactiplantibacillus plantarum as a Potential Adjuvant and Delivery System for the Development of SARS-CoV-2 Oral Vaccines
    Julio Villena, Chang Li, María Guadalupe Vizoso-Pinto, Jacinto Sacur, Linzhu Ren, Haruki Kitazawa · 2021 · Microorganisms
  15. In vitro Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms
    Ria Lassaunière, Jannik Fonager, Morten Rasmussen, Anders Frische, Charlotta Polacek, Thomas Bruun Rasmussen, Louise Lohse, Graham J. Belsham, Alexander P. Underwood, Anni Assing Winckelmann et al. · 2021 · Frontiers in Microbiology
  16. Co-crystallization and structure determination: An effective direction for anti-SARS-CoV-2 drug discovery
    Zhonglei Wang, Liyan Yang, Xian‐En Zhao · 2021 · Computational and Structural Biotechnology Journal
  17. SARS-COV-2, infection, transmission, transcription, translation, proteins, and treatment: A review
    Jahangir Emrani, Maryam Ahmed, Liesl K. Jeffers-Francis, John C. Teleha, Chishimba Nathan Mowa, Robert Howard Newman, Misty D. Thomas · 2021 · International Journal of Biological Macromolecules
  18. Structure and Mutations of SARS-CoV-2 Spike Protein: A Focused Overview
    Rukmankesh Mehra, Kasper P. Kepp · 2021 · ACS Infectious Diseases
  19. Mechanisms contributing to adverse outcomes of COVID-19 in obesity
    Manu Sudhakar, Winfred Sofi Beaula, Gowri Meiyazhagan, Venkatachalam Deepa Parvathi · 2022 · Molecular and Cellular Biochemistry
  20. SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
    Hatem A. Elshabrawy · 2020 · Vaccines
  21. Gastrointestinal Symptoms Associated With Unfavorable Prognosis of COVID-19 Patients: A Retrospective Study
    Rong Chen, Yanli Yu, Wei Li, Ya Liu, Jingxiao Lu, Fangyue Chen, Qin Zhou, Zhongyuan Xia, Ling Gao, Qingtao Meng et al. · 2020 · Frontiers in Medicine
  22. Docking and in silico toxicity assessment of Arthrospira compounds as potential antiviral agents against SARS-CoV-2
    Léna Petit, Léa Vernès, Jean‐Paul Cadoret · 2021 · Journal of Applied Phycology
  23. Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domain
    Zachariah P. Schuurs, Edward Hammond, Stefano Elli, Timothy Robert Rudd, Courtney J. Mycroft‐West, Marcelo Andrade de Lima, Mark Andrew Skidmore, Richard Torbjörn Gustav Karlsson, Yen‐Hsi Chen, Ieva Bagdonaite et al. · 2021 · Computational and Structural Biotechnology Journal
  24. The Development of SARS-CoV-2 Variants: The Gene Makes the Disease
    Raquel Pérez-Gómez · 2021 · Journal of Developmental Biology
  25. A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2
    Thomas S. Fulford, Huy Trần Văn, Nicholas A. Gherardin, Shuning Zheng, Marcin Ciula, Heidi E. Drummer, Samuel J. Redmond, Hyon‐Xhi Tan, Irene Boo, Fan Li et al. · 2021 · EBioMedicine
  26. Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2
    Tomokazu Ohishi, Takayuki Hishiki, Mirza S. Baig, Sajjan Rajpoot, Uzma Saqib, Tomohiko Takasaki, Yukihiko Hara · 2022 · PLoS ONE
  27. Potential of Nano-Antioxidants and Nanomedicine for Recovery from Neurological Disorders Linked to Long COVID Syndrome
    Thelma Akanchise, Angelina Angelova · 2023 · Antioxidants
  28. Recent developments in molecular modeling tools and applications related to pharmaceutical and biomedical research
    Paola Peluso, Bezhan Chankvetadze · 2023 · Journal of Pharmaceutical and Biomedical Analysis
  29. Human transferrin receptor can mediate SARS-CoV-2 infection
    Zhiyi Liao, Chaoming Wang, Xiaopeng Tang, Mengli Yang, Zilei Duan, Lei Liu, Shuaiyao Lu, Lei Ma, Ruomei Cheng, Wang Gan et al. · 2024 · Proceedings of the National Academy of Sciences
  30. COVID-19 : physiopathologie d’une maladie à plusieurs visages
    Vincent Bonny, Alexis Maillard, Cyril Mousseaux, Léo Plaçais, Quentin Richier · 2020 · La Revue de Médecine Interne
  31. Recent Understandings Toward Coronavirus Disease 2019 (COVID-19): From Bench to Bedside
    Jie Yu, Peiwei Chai, Shengfang Ge, Xianqun Fan · 2020 · Frontiers in Cell and Developmental Biology
  32. Flexible, Functional, and Familiar: Characteristics of SARS-CoV-2 Spike Protein Evolution
    Dianita S. Saputri, Songling Li, Floris J. van Eerden, John Rozewicki, Zichang Xu, Hendra Saputra Ismanto, Ana Davila, Shunsuke Teraguchi, Kazutaka Katoh, Daron M. Standley · 2020 · Frontiers in Microbiology
  33. High-throughput virtual screening of drug databanks for potential inhibitors of SARS-CoV-2 spike glycoprotein
    Ibrahim E. Awad, Abd Al‐Aziz A. Abu‐Saleh, Sweta Sharma, Arpita Yadav, Raymond A. Poirier · 2020 · Journal of Biomolecular Structure and Dynamics
  34. ACE2: from protection of liver disease to propagation of COVID-19
    Fiona J. Warner, Harinda Rajapaksha, Nicholas Adam Shackel, Chandana B. Herath · 2020 · Clinical Science
  35. A high-affinity RBD-targeting nanobody improves fusion partner’s potency against SARS-CoV-2
    Hebang Yao, Hongmin Cai, Tingting Li, Bingjie Zhou, Wenming Qin, Dimitri Lavillette, Dianfan Li · 2021 · PLoS Pathogens
  36. Computational Mutagenesis at the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Binding Interface: Comparison with Experimental Evidence
    Erik Laurini, Domenico Marson, Suzana Aulić, Alice Fermeglia, Sabrina Pricl · 2021 · ACS Nano
  37. Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs
    Anita Gupta, Gopal S. Gupta · 2021 · Molecular and Cellular Biochemistry
  38. Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues
    Leentje Persoons, Evelien Vanderlinden, Laura Vangeel, Xinyu Wang, Thuc Nguyen Dan, Caroline Shi-Yan Foo, Pieter Leyssen, Johan H. Neyts, Dirk Jochmans, Dominique Schols et al. · 2021 · Antiviral Research
  39. Inhibition of ACE2‐Spike Interaction by an ACE2 Binder Suppresses SARS‐CoV‐2 Entry
    Young‐Hee Shin, Kiyoung Jeong, Jihye Lee, Hyo‐Jung Lee, Junhyeong Yim, Jonghoon Kim, Seungtaek Kim, Seung Bum Park · 2022 · Angewandte Chemie International Edition
  40. A Novel Soluble ACE2 Protein Provides Lung and Kidney Protection in Mice Susceptible to Lethal SARS-CoV-2 Infection
    Luise Hassler, Jan A Wysocki, Ian Arthur Gelarden, Isha Sharma, Αναστασία Τοματσίδου, Minghao Ye, Haley Gula, Vlad Nicoleascu, Glenn C. Randall, Sergii Pshenychnyi et al. · 2022 · Journal of the American Society of Nephrology
  41. Activation of ang-(1-7)/mas receptor is a possible strategy to treat coronavirus (SARS-CoV-2) infection
    Magalhaes, Giselle Santos, Rodrigues-Machado, Maria da Gloria, Motta-Santos, Daisy, Campagnole-Santos, Maria Jose, Santos, Robson A. Souza · 2020 · Frontiers in Physiology
  42. Ligand‐centered assessment of SARS‐CoV‐2 drug target models in the Protein Data Bank
    Alexander Wlodawer, Zbigniew Dauter, Ivan G. Shabalin, Miroslaw J. Gilski, Dariusz Brzeziński, Marcin Kowiel, Wladek Minor, Bernhard Rupp, Mariusz Jaskólski · 2020 · FEBS Journal
  43. Mechanism and evolution of human ACE2 binding by SARS-CoV-2 spike
    Antoni G. Wrobel · 2023 · Current Opinion in Structural Biology
  44. Engineering Cellular Vesicles for Immunotherapy
    Xinyu Lin, Ludan Yue, Ke Cheng, Lang Rao · 2025 · Accounts of Materials Research
  45. SARS-CoV-2 and Viral Sepsis: Immune Dysfunction and Implications in Kidney Failure
    Alessandra Stasi, Giuseppe Castellano, Elena Ranieri, Barbara Infante, Giovanni Stallone, Loreto Gesualdo, Giuseppe Stefano Netti · 2020 · Journal of Clinical Medicine
  46. Axial Chiral Binaphthoquinone and Perylenequinones from the Stromata of Hypocrella bambusae Are SARS-CoV-2 Entry Inhibitors
    Yuting Li, Chan Yang, Yan Ling Wu, Jun‐Jiang Lv, Xiao Feng, Xiaofei Tian, Zhengzheng Zhou, Xiaoyan Pan, Shuwen Liu, Liwen Tian · 2021 · Journal of Natural Products
  47. The SARS‐unique domain (SUD) of SARS‐CoV and SARS‐CoV‐2 interacts with human Paip1 to enhance viral RNA translation
    Jian Lei, Yue Ma-Lauer, Yinze Han, M. Thoms, R. Buschauer, J. Jores, V. Thiel, R. Beckmann, Wen Deng, H. Leonhardt et al. · 2021 · EMBO Journal
  48. COVID-19-related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the ESC Working Group on Cellular Biology of the Heart
    Maurizio Pesce, Piergiuseppe Agostoni, Hans Erik Bøtker, Bianca J.J.M. Brundel, Sean M. Davidson, Raffaele De Caterina, Péter Ferdinandy, Henrique Girão, Mariann Gyöngyösi, Jean‐Sébastien Hulot et al. · 2021 · Cardiovascular Research
  49. Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 Variants
    Linda van Oosten, Jort J. Altenburg, Cyrielle E. Fougeroux, Corinne Geertsema, Fred van den End, Wendy A. C. Evers, Adrie H. Westphal, Simon Lindhoud, W. van den Berg, Daan C. Swarts et al. · 2021 · mBio
  50. Atomistic simulation reveals structural mechanisms underlying D614G spike glycoprotein‐enhanced fitness in SARS‐COV ‐2
    Olaposi Idowu Omotuyi, Oyekanmi Nash, O. Basiru Ajiboye, C. Gift Iwegbulam, E. Babatunji Oyinloye, O. Abimbola Oyedeji, Z. Abimbola Kashim, Kunle Okaiyeto · 2020 · Journal of Computational Chemistry
  51. Multiple functions of stress granules in viral infection at a glance
    Yuelin Guan, Yan Wang, Xudong Fu, Guannan Bai, Xue Li, Jian‐Hua Mao, Yong‐Bin Yan, Lidan Hu · 2023 · Frontiers in Microbiology
  52. Human coronavirus spike protein-host receptor recognition
    Lalitha Guruprasad · 2020 · Progress in Biophysics and Molecular Biology
  53. Review of COVID‐19 and male genital tract
    Farzam Sheikhzadeh Hesari, Seyedeh Shaghayegh Hosseinzadeh, Mohammad Ali Asl Monadi Sardroud · 2020 · Andrologia
  54. Conformational flexibility and structural variability of SARS-CoV2 S protein
    Ishika Pramanick, Nayanika Sengupta, Suman Mishra, Suman Pandey, Nidhi Girish, Alakta Das, Somnath Dutta · 2021 · Structure
  55. Variable posttranslational modifications of severe acute respiratory syndrome coronavirus 2 nucleocapsid protein
    Nitin T. Supekar, Asif Shajahan, Anne S. Gleinich, Daniel S. Rouhani, Christian Heiß, Digantkumar Gopaldas Chapla, Kelley W. Moremen, Parastoo Azadi · 2021 · Glycobiology
  56. ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions
    Daniel J. Rawle, Thuy T. Le, Troy D. Dumenil, Kexin Yan, Bing Tang, Wilson Nguyen, Daniel Watterson, Naphak Modhiran, Jody Hobson‐Peters, Cameron Bishop et al. · 2021 · PLoS Pathogens
  57. Role of genetic variants and host polymorphisms on COVID‐19: From viral entrance mechanisms to immunological reactions
    Abolfazl Adli, Mandana Rahimi, Reza Khodaie, Niloofar Hashemzaei, Sayed Mostafa Hosseini · 2022 · Journal of Medical Virology
  58. Cryo-EM Structures Delineate a pH-Dependent Switch that Mediates Endosomal Positioning of SARS-CoV-2 Spike Receptor-Binding Domains
    Tongqing Zhou, Yaroslav Tsybovsky, Adam S. Olia, Jason Gorman, Micah Rapp, Gabriele Cerutti, Gwo‐Yu Chuang, Phinikoula S. Katsamba, Alexandra F. Nazzari, Jared M. Sampson et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  59. Transferrin receptor is another receptor for SARS-CoV-2 entry
    Xiaopeng Tang, Mengli Yang, Zilei Duan, Zhiyi Liao, Lei Liu, Ruomei Cheng, Mingqian Fang, Wang Gan, Hongqi Liu, Jingwen Xu et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  60. Viral pathogenesis of SARS-CoV-2 infection and male reproductive health
    Shubhadeep Roychoudhury, Anandan Das, Kavindra Kumar Kesari, Kavindra Kumar Kesari, Shatabhisha Roychoudhury, Saurabh Kumar Jha, Raghavender Goud Kosgi SR, Arun Paul Choudhury, Norbert Lukáč, Nithar Ranjan Madhu et al. · 2021 · Open Biology
  61. Understanding the Molecular Biology of SARS-CoV-2 and the COVID-19 Pandemic: A Review
    Sarah F. Alsobaie · 2021 · Infection and Drug Resistance
  62. Interaction of selected terpenoids with two SARS-CoV-2 key therapeutic targets: An in silico study through molecular docking and dynamics simulations
    Salvatore Vincenzo Giofrè, Edoardo Napoli, Nunzio Iraci, Antonio Speciale, Francesco Cimino, Claudia Muscarà, Maria Sofia Molonia, Giuseppe Ruberto, Antonella Saija · 2021 · Computers in Biology and Medicine
  63. Investigation of nonsynonymous mutations in the spike protein of SARS-CoV-2 and its interaction with the ACE2 receptor by molecular docking and MM/GBSA approach
    Reem Yussuf AlJindan, Abeer M. Al‐Subaie, Ahoud I. Al-Ohali, D. Thirumal Kumar, C. George Priya Doss, Balu Kamaraj · 2021 · Computers in Biology and Medicine
  64. Generation of a Sleeping Beauty Transposon-Based Cellular System for Rapid and Sensitive Screening for Compounds and Cellular Factors Limiting SARS-CoV-2 Replication
    Marek Widera, Alexander Wilhelm, Tuna Toptan, Johanna M. Raffel, Eric Kowarz, Fabian Roesmann, Finn Grözinger, Anna Lena Siemund, Vanessa Luciano, Marius Külp et al. · 2021 · Frontiers in Microbiology
  65. Trypsin enhances SARS-CoV-2 infection by facilitating viral entry
    Yeeun Kim, Guehwan Jang, Duri Lee, Nara Kim, Jeong Won Seon, Young-Hoan Kim, Changhee Lee · 2022 · Archives of Virology
  66. Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs
    Lipin Loo, Matthew A. Waller, Cesar L. Moreno, Alexander J. Cole, Alberto Ospina Stella, Oltin-Tiberiu Pop, Ann-Kristin Jochum, Omar Hasan Ali, Christopher E. Denes, Zina Hamoudi et al. · 2023 · PLoS Biology
  67. Nucleic acid-based therapy for coronavirus disease 2019
    Ravikant Piyush, Keshav Rajarshi, Aroni Chatterjee, Rajni Khan, Shashikant Ray · 2020 · Heliyon
  68. SARS-CoV-2 mutation 614G creates an elastase cleavage site enhancing its spread in high AAT-deficient regions
    Chandrika Bhattacharyya, Chitrarpita Das, Arnab Ghosh, Animesh Kumar Singh, Souvik Mukherjee, Partha Pratim Majumder, Analabha Basu, Nidhan K. Biswas · 2021 · Infection Genetics and Evolution
  69. Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins
    Kim M. Bouwman, Ilhan Tomris, Hannah L. Turner, Roosmarijn van der Woude, Tatiana M. Shamorkina, Gerlof P. Bosman, Barry Rockx, Sander Herfst, Joost Snijder, Bart L. Haagmans et al. · 2021 · PLoS Pathogens
  70. Comparative Immunogenicity of the Recombinant Receptor-Binding Domain of Protein S SARS-CoV-2 Obtained in Prokaryotic and Mammalian Expression Systems
    Iuliia A. Merkuleva, D. Shcherbakov, M. B. Borgoyakova, D. Shanshin, A. P. Rudometov, L. Karpenko, S. Belenkaya, A. A. Isaeva, V. S. Nesmeyanova, E. Kazachinskaia et al. · 2022 · Vaccines
  71. SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry
    Bo Yang, Yuanyuan Jia, Yumin Meng, Ying Xue, Kefang Liu, Yan Li, Shichao Liu, Xiaoxiong Li, Kaige Cui, Lina Shang et al. · 2022 · Proceedings of the National Academy of Sciences
  72. Molecular Virology of SARS-CoV-2 and Related Coronaviruses
    Yu-An Kung, Kuo-Ming Lee, Huan-Jung Chiang, Sheng‐Yu Huang, Chung-Jung Wu, Shin‐Ru Shih · 2022 · Microbiology and Molecular Biology Reviews
  73. Susceptibilities of Human ACE2 Genetic Variants in Coronavirus Infection
    Wenlin Ren, Yunkai Zhu, Jun Lan, Hedi Chen, Yuyan Wang, Hongyang Shi, Fei Feng, D. W. Chen, Brianna J. Close, Xiaomin Zhao et al. · 2021 · Journal of Virology
  74. Trends of mutation accumulation across global SARS-CoV-2 genomes: Implications for the evolution of the novel coronavirus
    Chayan Roy, Santi M. Mandal, Suresh Kumar Mondal, Shriparna Mukherjee, Tarunendu Mapder, Wriddhiman Ghosh, Ranadhir Chakraborty · 2020 · Genomics
  75. Kinetics and isotype assessment of antibodies targeting the spike protein receptor‐binding domain of severe acute respiratory syndrome‐coronavirus‐2 in COVID‐19 patients as a function of age, biological sex and disease severity
    Nancy R. Graham, Annalis Whitaker, Camilla A. Strother, Ashley K. Miles, Dore Grier, Benjamin D. McElvany, Emily A. Bruce, Matthew E. Poynter, Kristen K. Pierce, Beth D. Kirkpatrick et al. · 2020 · Clinical & Translational Immunology
  76. A natural food preservative peptide nisin can interact with the SARS-CoV-2 spike protein receptor human ACE2
    Rajarshi Bhattacharya, Aayatti Mallick Gupta, Suranjita Mitra, Sukhendu Mandal, Swadesh Ranjan Biswas · 2020 · Virology
  77. Development of a Fast SARS-CoV-2 IgG ELISA, Based on Receptor-Binding Domain, and Its Comparative Evaluation Using Temporally Segregated Samples From RT-PCR Positive Individuals
    Farha Mehdi, Souvick Chattopadhyay, Ramachandran Thiruvengadam, Yadav Sarla, Manjit Kumar, Sangita Kumari Sinha, Sandeep Goswami, Pallavi Kshetrapal, Nitya Wadhwa, Uma Chandra Mouli Natchu et al. · 2021 · Frontiers in Microbiology
  78. Mutations of SARS-CoV-2 RBD May Alter Its Molecular Structure to Improve Its Infection Efficiency
    Ahmed L. Alaofi, Mudassar Shahid · 2021 · Biomolecules
  79. Kinetics of specific anti-SARS-CoV-2 IgM, IgA, and IgG responses during the first 12 months after SARS-CoV-2 infection: A prospective longitudinal study
    Houda Amellal, Najlaa Assaid, Hicham Charoute, Khadija Akarid, Abderrahmane Maaroufi, Sayeh Ezzikouri, M’hammed Sarih · 2023 · PLoS ONE
  80. Markov State Models and Perturbation-Based Approaches Reveal Distinct Dynamic Signatures and Hidden Allosteric Pockets in the Emerging SARS-Cov-2 Spike Omicron Variant Complexes with the Host Receptor: The Interplay of Dynamics and Convergent Evolution Modulates Allostery and Functional Mechanisms
    Sian Xiao, Mohammed Alshahrani, Grace Gupta, Peng Tao, Gennady M. Verkhivker · 2023 · Journal of Chemical Information and Modeling
  81. Key mechanistic features of the trade-off between antibody escape and host cell binding in the SARS-CoV-2 Omicron variant spike proteins
    Weiwei Li, Zepeng Xu, Tianhui Niu, Yufeng Xie, Zhennan Zhao, Dedong Li, Qingwen He, Wenqiao Sun, Kaiyuan Shi, Wenjing Guo et al. · 2024 · The EMBO Journal
  82. ACE2, the Receptor that Enables Infection by SARS‐CoV‐2: Biochemistry, Structure, Allostery and Evaluation of the Potential Development of ACE2 Modulators
    Lissy Z. F. Gross, Mariana Sacerdoti, Albrecht Piiper, Stefan Zeuzem, Alejandro E. Leroux, Ricardo M. Biondi · 2020 · ChemMedChem
  83. Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike
    João M. Trigueiro-Louro, Vanessa Correia, Inês Figueiredo-Nunes, Marta Gíria, Helena Rebelo‐de‐Andrade · 2020 · Computational and Structural Biotechnology Journal
  84. Binding of SARS‐CoV‐2 to Cell Receptors: A Tale of Molecular Evolution
    Santiago A. Gómez, Natalia Rojas‐Valencia, Sara Gómez, Franco Egidi, Chiara Cappelli, Albeiro A. Restrepo · 2020 · ChemBioChem
  85. Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients
    Q. Yan, P. He, Xiaohan Huang, K. Luo, Yu-Di Zhang, Haisu Yi, Qian Wang, Feng Li, Rui-Tian Hou, Xiaodi Fan et al. · 2021 · Emerging Microbes and Infections
  86. Carbon Nanotube Mask Filters and Their Hydrophobic Barrier and Hyperthermic Antiviral Effects on SARS-CoV-2
    Sangsu Lee, Jeong‐Seok Nam, Jiye Han, Qiang Zhang, Esko I. Kauppinen, Il Jeon · 2021 · ACS Applied Nano Materials
  87. Diabetes and COVID-19: Role of insulin resistance as a risk factor for COVID-19 severity
    Charitha Gangadharan, Rupa Ahluwalia, Alben Sigamani · 2021 · World Journal of Diabetes
  88. Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variants
    Wan-Ling Wu, Chen-Yi Chiang, Szu-Chia Lai, Chia-Yi Yu, Yu‐Ling Huang, Hung‐Chun Liao, Ching‐Len Liao, Hsin–Wei Chen, Shih‐Jen Liu · 2022 · JCI Insight
  89. Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor
    Tümay Capraz, Nikolaus F. Kienzl, Elisabeth Laurent, Jan Walther Perthold, Esther Föderl-Höbenreich, Clemens Grünwald‐Gruber, Daniel Maresch, Vanessa Monteil, Janine Niederhöfer, Gerald Wirnsberger et al. · 2021 · eLife
  90. Single-Cell Immunobiology of the Maternal–Fetal Interface
    Derek Miller, Valeria Garcia‐Flores, Roberto J. Romero, José Galaz, Roger Piqué-Regi, Nardhy Gomez‐Lopez · 2022 · The Journal of Immunology
  91. Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection
    Titus Abiola Olukitibi, Zhujun Ao, Bryce M. Warner, Rodrigo Unat, Darwyn Kobasa, Xiaojian Yao · 2023 · Vaccines
  92. The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection
    Amirhosein Faghihkhorasani, Hanan Hassan Ahmed, Noor Muhammad Mashool, Mariem Alwan, Marjan Assefi, Aya Hussein Adab, Saman Yasamineh, Omid Gholizadeh, Moein Baghani · 2023 · Virology Journal
  93. Classification of five SARS-CoV-2 serotypes based on RBD antigenicities
    Shixiong Hu, Chunli Wu, Xinkai Wu, Xuehui Ma, Chang Shu, Qian Chen, Anqi Zheng, Huiting Yang, Jian Lü, Pei Du et al. · 2023 · 中国科学通报:英文版
  94. Thermodynamics of the Interaction between the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus‑2 and the Receptor of Human Angiotensin-Converting Enzyme 2. Effects of Possible Ligands
    Cristina García‐Iriepa, Cécilia Hognon, Antonio Francés‐Monerris, Isabel Iriepa, Tom Miclot, Giampaolo Barone, Antonio Monari, Marco Marazzi · 2020 · The Journal of Physical Chemistry Letters
  95. ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
    Sara Ravaioli, Michela Tebaldi, Eugenio Fonzi, Davide Angeli, Massimiliano Mazza, Fabio Nicolini, Alessandro Lucchesi, Francesca Fanini, Francesca Pirini, Maria Maddalena Tumedei et al. · 2020 · Cell Transplantation
  96. Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?
    Ligong Lu, Hui Zhang, Meixiao Zhan, Jun Jiang, Hua Yin, Danielle J. Dauphars, Shi-You Li, Yong Li, You-Wen He · 2020 · Science China Life Sciences
  97. Animal Coronaviruses and SARS-COV-2 in Animals, What Do We Actually Know?
    Paolo Bonilauri, Gianluca Rugna · 2021 · Life
  98. D936Y and Other Mutations in the Fusion Core of the SARS-CoV-2 Spike Protein Heptad Repeat 1: Frequency, Geographical Distribution, and Structural Effect
    Romina Oliva, Abdul Rajjak Shaikh, Andrea Petta, Anna Vangone, Luigi Cavallo · 2021 · Molecules
  99. Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative
    Sameer Kumar Malladi, Unnatiben Rajeshbhai Patel, Raju S Rajmani, Randhir Singh, Suman Pandey, Sahil Kumar, Sara Khaleeq, Petrus Jansen van Vuren, Shane Riddell, Sarah Goldie et al. · 2021 · ACS Infectious Diseases
  100. Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation
    Wei Wang, Shasha Li, Xinfeng Xu, Chan Yang, Xiaoge Niu, Shuxian Yin, Xiaoyan Pan, Wei Xü, Guodong Hu, Chan Wang et al. · 2021 · Acta Pharmacologica Sinica